Haplogen is a young biopharmaceutical company with the mission to improve human health by combating infectious disease and metabolic disorders.
| Website | http://www.haplogen.com |
| Revenue | $9 million |
| Employees | View employees |
| Founded | 2017 |
| Address | Biocenter 3, Vienna, Vienna, AT |
| Phone | +1 431-916-5522 |
| Industry | Biotechnology Research, Pharmaceuticals, Healthcare, Biotechnology, Drug Manufacturing & Research |
| Competitors | AbbVie, The Janssen Pharmaceutical Companies of Johnson & Johnson, GSK, AstraZeneca, SUN PHARMA, Moderna Therapeutics, Vir Biotechnology, Inc., Novavax, Lilly India, ViroFend Therapeutics S.L. +39 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 541713 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies |
Looking for a particular Haplogen Bioscience employee's phone or email?
The Haplogen Bioscience annual revenue was $9 million in 2026.
Haplogen Bioscience is based in Vienna, Vienna.
The NAICS codes for Haplogen Bioscience are [541713, 54171, 541, 54, 5417].
The SIC codes for Haplogen Bioscience are [87, 873].